
Exposure to antiretroviral therapy and risk of cancer in HIV-infected persons
Author(s) -
Chun Chao,
Wendy A. Leyden,
Lanfang Xu,
Michael A. Horberg,
Daniel B. Klein,
William Towner,
Charles P. Quesenberry,
Donald I. Abrams,
Michael J. Silverberg
Publication year - 2012
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0b013e32835935b3
Subject(s) - medicine , reverse transcriptase inhibitor , cancer , confidence interval , viral load , antiretroviral therapy , immunology , human immunodeficiency virus (hiv)
The incidence of certain non-AIDS-defining cancers (NADCs) in HIV patients has been reported to have increased in the combination antiretroviral therapy (ART) era. Studies are needed to directly evaluate the effect of ART use on cancer risk.